ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )
🇨🇳China
3D-MRE for Assessing Cirrhosis and Portal Hypertension
Recruiting
- Conditions
- Cirrhosis, LiverPortal Hypertension
- Interventions
- Device: 3D-MREDevice: HVPG
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05475015
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC
Phase 2
- Conditions
- Breast Cancer
- Interventions
- Combination Product: Chidamide
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT05400993
- Locations
- 🇨🇳
Bethune First Hospital of Jilin University, Changchun, Jilin, China
🇨🇳Cancer Hospital affiliated to Harbin Medical University, Haerbin, Heilongjiang, China
🇨🇳Health Science and Technology Information Center of Liaoning Health Industry Group Co., LTD, Benxi, Liaoning, China
Dreaming During Anesthesia and Anesthetic Depth in Elective Surgery Patients Under General Anesthesia
Not Applicable
- Conditions
- DreamingGeneral Anesthesia
- Interventions
- Device: deep anesthesia depthDevice: light anesthesia depth
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05357872
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Procedure: ALND Group
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05346510
- Locations
- 🇨🇳
Liaoning Oncology Hospital, Shenyang, Liaoning, China
Ultrasound Measurements of Circular Cartilage Transverse Diameter
Not Applicable
- Conditions
- Ultrasound Therapy; ComplicationsTransverse Diameter of Cricoid CartilageChildrenEndotracheal Intubation
- Interventions
- Device: Portable color Doppler ultrasound system
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT05273294
- Locations
- 🇨🇳
Junchao Zhu, Shenyang, China
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: Standard Therapy
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05263570
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Breast Neoplasms
- Interventions
- Drug: Chidamide combined with exemestane (+/- goserelin)Drug: Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT05253066
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Procedure: SLNBProcedure: ALNDProcedure: pALND
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05241119
- Locations
- 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
🇨🇳Jianyi Li, Shenyang, Liaoning, China
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Phase 2
Recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05228951
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
The Effect of Gravity on the Occurrence of Lactational Mastitis
- Conditions
- Lactation Mastitis
- Interventions
- Other: provides guidance on gravitationally assisted breastfeeding
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05207241
- Locations
- 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
© Copyright 2025. All Rights Reserved by MedPath